Quadrant Capital Group’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-326	Closed	-$8.05K	–	2737
2024 Q3	$8.05K	Hold	326	–	–	﹤0.01%	2204
2024 Q2	$8.26K	Sell	326 -190	-37%	-$4.92K	﹤0.01%	2177
2024 Q1	$13.1K	Buy	516 +190	+58%	+$4.6K	﹤0.01%	2003
2023 Q4	$7.39K	Buy	326 +270	+482%	+$5.59K	﹤0.01%	2168
2023 Q3	$1.04K	Sell	56 -1,148	-95%	-$23.8K	﹤0.01%	2483
2023 Q2	$31.3K	Buy	1,204 +40	+3%	+$1.07K	﹤0.01%	1486
2023 Q1	$33.4K	Buy	1,164 +12	+1%	+$357	﹤0.01%	1448
2022 Q4	$34.1K	Buy	1,152 +80	+7%	+$2.28K	﹤0.01%	1396
2022 Q3	$26K	Buy	1,072 +1,043	+3,597%	+$24K	﹤0.01%	1400
2022 Q2	$1K	Buy	+29	New	+$647	﹤0.01%	2315
2018 Q4	–	Sell	-20	Closed	–	–	2195
2018 Q3	$0	Hold	20	–	–	﹤0.01%	2130
2018 Q2	$0	Hold	20	–	–	﹤0.01%	2146
2018 Q1	$0	Hold	20	–	–	﹤0.01%	2157
2017 Q4	$1K	Hold	20	–	–	﹤0.01%	1912
2017 Q3	$1K	Hold	20	–	–	﹤0.01%	1921
2017 Q2	$0	Hold	20	–	–	﹤0.01%	1854
2017 Q1	$0	Hold	20	–	–	﹤0.01%	2060
2016 Q4	$0	Hold	20	–	–	﹤0.01%	1990
2016 Q3	$0	Hold	20	–	–	﹤0.01%	1991
2016 Q2	$1K	Hold	20	–	–	﹤0.01%	1572
2016 Q1	$0	Buy	+20	New	+$811	﹤0.01%	1801

Other funds holding ANIK